Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma(Clin Cancer Res (2015)21(30–8)DOI: 10.1158/1078-0432.CCR-14-1716)

Joseph A. Califano, Zubair Khan, Kimberly Noonan, Lakshmi Rudraraju, Zhe Zhang, Hao Wang, Steven Goodman, Christine G. Gourin, Patrick Ha, Carole Fakhry, John Saunders, Marshall A. Levine, Mei Tang, Geoffrey Neuner, Jeremy D Richmon, Ray Gervacio F. Blanco, Nishant Agrawal, Wayne M. Koch, Shanthi Marur, Donald T. WeedPaolo Serafini, Ivan M Borrello

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

In the original version of this article (1), the authors did not disclose that the investigational agent used, tadalafil, was supplied by Lilly, Inc. This information is now included in the Acknowledgements. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish (US)
Pages (from-to)6100
Number of pages1
JournalClinical Cancer Research
Volume24
Issue number23
DOIs
StatePublished - Dec 1 2018

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma(Clin Cancer Res (2015)21(30–8)DOI: 10.1158/1078-0432.CCR-14-1716)'. Together they form a unique fingerprint.

Cite this